GlassScriptPhysician profile
Jessica Collins
NPI 1609221688
$8,131.43
in general payments reported to CMS, 2019-2025
28 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,790 · 2020: $175 · 2021: $230 · 2022: $2,492 · 2023: $1,492 · 2024: $1,344 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,373 · Travel and Lodging: $71.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.15 |
| Travel and Lodging | $71.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,927.72 | 2022-2023 | |
| Osteomed LLC | $1,526.40 | 2019-2020 | |
| Smith+Nephew, INC. | $997.28 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis |
| Organogenesis INC. | $835.33 | 2022-2025 | Affinity, Puraply, Puraply Wound Matrix |
| Depuy Synthes Sales INC. | $604.97 | 2020-2025 | Motoband, Va-Lcp, Fibulink |
| Stryker Corporation | $427.58 | 2021-2024 | 7 X 23mm Citrelock Implant, Citrefix, Prophecy |
| Kerecis Limited | $281.35 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Revance Therapeutics, INC. | $248.18 | 2024 | Daxxify |
| Wright Medical Technology, INC. | $228.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $224.72 | 2019-2022 | |
| Integra Lifesciences Corporation | $154.29 | 2021-2025 | Integra, Tcc-Ez, Integra Dermal Regeneration Template |
| Abbvie INC. | $142.57 | 2023-2024 | Dalvance |
| Paratek Pharmaceuticals, INC. | $79.18 | 2023-2025 | Nuzyra |
| Bioventus LLC | $73.71 | 2022-2024 | Durolane |
| Paragon 28, INC. | $50.26 | 2019-2023 | Gorilla |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.43 | 2024 | Xarelto |
| Mimedx Group, INC. | $32.65 | 2024-2025 | |
| Acera Surgical, INC. | $32.01 | 2022 | |
| Heraeus Medical, LLC. | $30.84 | 2023 | |
| Liberty Surgical INC. | $26.85 | 2019 | |
| Kci USA, INC. | $25.70 | 2022 | |
| Next Science LLC | $24.99 | 2023 | Surgx, Blastx, Xperience |
| Djo, LLC | $24.82 | 2020 | |
| Urgo Medical North America, LLC | $23.04 | 2025 | Urgoclean Ag |
| Convatec INC. | $20.37 | 2024 | |
| Lifenet Health | $20.26 | 2023 | |
| Amgen INC. | $16.42 | 2024 | Krystexxa |
| Treace Medical Concepts, INC. | $13.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.